A clinical study on the efficacy and safety of cutting seton and drainage therapy in the treatment of high perianal abscess

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100005098

Enrollment

Unknown

Registered

2021-07-25

Start date

2022-01-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Prianal Abscess

Interventions

Experimental group:Cutting Seton and Drainage therapy

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years, male or female; 2. Diagnosed by digital examination and anorectal B-ultrasound, it was confirmed as high perianal abscess; 3. No history of perianal abscess surgery and abnormal anal morphology and function; 4. Patients voluntarily participated in clinical trials, signed informed consent, and were able to cooperate with clinical follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, lung, brain, liver and kidney diseases; 2. Pregnant or planning pregnancy and lactating women; 3. The doctor determines that other medical history has an impact on anal function; 4. Others due to religious ethnicity, diabetes, cancer, intestinal tuberculosis, Crohn's disease, AIDS; 5. Allergic constitution or allergic to the drugs used after surgery.

Design outcomes

Primary

Measure	Time frame
Cure rate;Semi-annual recurrence rate;	—

Secondary

Measure	Time frame
Fecal incontinence severity score ;postoperative pain score;Healing time;Anorectal manometry;Incidence rate of adverse events;	—

Countries

China

Contacts

Public ContactShi Yuying

China-Japan Friendship Hospital

362948118@qq.com+86 13581583757

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026